Fukuoka, Japan

Daisuke Ura


Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Ohmuta, JP (1994)
  • Fukuoka, JP (1995 - 2000)
  • Omuta, JP (2007 - 2009)

Company Filing History:


Years Active: 1994-2009

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Daisuke Ura: Innovator in Chemical Processes

Introduction

Daisuke Ura is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of processes for producing various chemical compounds. With a total of 5 patents to his name, Ura's work has implications in both agriculture and medicine.

Latest Patents

One of Ura's latest patents is a process for producing nitroisourea derivatives. This improved process is essential for creating nitroguanidine derivatives that exhibit insecticidal activity. The method involves reacting specific nitroisourea derivatives with amines in the presence of a catalytic amount of hydrogen carbonate. Another notable patent is a method for producing 2-alkyl-3-aminothiophene derivatives. This method utilizes hydrogenation with a noble metal catalyst, allowing for high economic efficiency. The resulting compounds are valuable in the fields of medicine and agriculture, particularly as bactericides.

Career Highlights

Throughout his career, Daisuke Ura has worked with notable companies such as Mitsui Chemicals, Inc. and Mitsui Toatsu Chemicals, Incorporated. His experience in these organizations has contributed to his expertise in chemical processes and innovation.

Collaborations

Ura has collaborated with several professionals in his field, including Nobuhiro Fukuhara and Hiroyuki Katsuta. These collaborations have likely enhanced his research and development efforts.

Conclusion

Daisuke Ura's innovative work in chemical processes has led to significant advancements in the production of important compounds. His contributions continue to impact the fields of agriculture and medicine positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…